| ORIGINAL ARTICLE |
|
| Year : 2023 | Volume
: 66
| Issue : 2 | Page : 291-294 |
|
|
Zeta-associated protein 70 expression in chronic lymphocytic leukemia: Relevance in Indian context
Richa Gupta1, Neha Garg1, Abha Singh2, Shyam Lata Jain3
1 University College of Medical Sciences, Delhi, India
2 Dr. Ram Manohar Lohia Hospital and PG Institute, New Delhi, India
3 Maulana Azad Medical College, New Delhi, India
Correspondence Address:
Richa Gupta
Room No. 427, Department of Pathology, University College of Medical Sciences, Delhi
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/IJPM.IJPM_1200_20
|
|
|
Background: Chronic lymphocytic leukemia (CLL) is prognosticated using the Rai and the Binet's staging. In the past few years, new parameters have been considered for prognostication. One such marker that has been a subject of speculation and found useful by some western studies is zeta-associated protein 70 (ZAP-70). Aim: To investigate the prevalence of ZAP-70 and find out its association with other prognostic markers like Rai and Binet's stage and CD38 in Indian CLL patients. Materials and Methods: Twenty-nine newly diagnosed cases of CLL were selected over 1 year. Immunophenotyping was done and expression of CD38 and ZAP-70 was evaluated on gated CLL cells. Statistical Analysis: Qualitative data were expressed as frequency and percentage. Differences between groups were evaluated using Student's t-test for quantitative data and Chi-square test/Fisher's exact t-test for qualitative variables. A P value less than 0.05 was considered significant. Results and Conclusion: We found a lower prevalence rate of ZAP-70 (2/29, 6.89%) with no association with any of the conventional poor prognostic factors. A large number of our CLL patients fall into the good prognostic group (22/29, ZAP 70−/CD38−) with a least number in the poor prognostic group (2/29, ZAP-70 + CD38+). Also, no association was found between ZAP-70 and CD38. The findings of the present study suggest that the majority of CLL patients in India have a good prognosis, may not require treatment, and have good overall survival. Geographical variations, genetic makeup, and natural history of the CLL could be the cause of such differences from western literature.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
